(Q38461360)
Statements
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study (English)
Danial Khajavi
Mehdi Farokhnia
Amirhossein Modabbernia
Mandana Ashrafi
Seyed-Hesammedin Abbasi
16 October 2012